Dong-A ST Co Ltd

Overview

Dong-A ST Co Ltd (Dong-A ST) is a pharmaceutical company. It manufactures and sells ethical drugs, medical devices, and diagnostic tests in South Korea. The company offers ethical drugs including gonadopin injection, dulastin progression-free survival, mainta injection, monotaxel injection, motilitone tablet, suganon tablet, sugamet XR tablet, closerin capsule, growtropin II , and leucostim. It also offers diagnostic solutions for identification of Malaria, dengue combo, anti-HBs, HBsAg, Hepatitis C, HIV 1/2, Syphilis and Ebola Ag diseases. The company is also engaged in the research to develop new drugs. Dong-A ST is headquartered in Seoul, South Korea.
Key Stats
Address
64, Cheonho-daero, Dongdaemun-gu, Dongdaemun-gu, SEOUL, South Korea
Headquarters

South Korea

Contact

82 2 9208114

No of Employees

1,591

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

170900 [KOSE]

Revenue (2020)

$498 m

-5.3% (2020 vs 2019)
Net Income (2020)

$23 m

-62.2% (2020 vs 2019)
Net Profit Margin

5 %

-60.1% (2020 vs 2019)
Market Cap *

$566 m

EPS *

$2.7

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Dong-A ST Co LtdYuhan CorpHanmi Pharmaceuticals Co LtdHanmi Science Co Ltd
Key Information
Headquarters South Korea South Korea South Korea South Korea
Headquarter City SEOUL SEOUL HWASEONG HWASEONG
Headquarter State/Province - - - -
No. of Employees 1,591 1,594 2,095 98
Entity Type Public Public Public Public

Products & Services

Dong-A ST is a medical device manufacturing company. The company's key products and services include the following:

Products
  • Ethical Drugs:
  • Gonadopin Injection
  • Dulastin Progression-Free Survival (PFS)
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Services
  • Supply of Artificial Cardiac Crcuits
  • Import and Supply of Medical Devices
  • Supply of Micro Fixation Implants for Use in Artificial Joints (Hip, Knee and Shoulder) and Plastic Surgery
  • Etiam Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Dae-Sik Eom Chief Executive Officer; Director Executive Board 2018 - Mr. Dae-Sik Eom has been the Director and Chief Executive Officer of the company since March 2018. He also serves...
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Contracts/Agreements In March, the company and E& Investment entered into an agreement, in which Dong-A ST…
2021 Contracts/Agreements In July, the company and Meiji Seika Pharma Co Ltd entered into an exclusive license…
2020 Contracts/Agreements In July, the company entered into an agreement with Takeda Pharmaceuticals Korea to sell Edarbi,…
2019 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2019 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2018 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
09 Jun 2021 Dong-A ST Raises USD90 Million in Public Offering of Convertible Bonds Due 2026 Debt Offering Dong-A ST Co Ltd
12 Mar 2021 Dong-A ST to Acquire NeuroBo Pharma Acquisition Dong-A ST Co Ltd NeuroBo Pharmaceuticals Inc
05 Mar 2021 Novelty Nobility Raises USD7 Million in Bridge Financing Venture Financing Dong-A ST Co Ltd; K2 Investment Partners LLC; Daily Partners Co., Ltd.; Mega Investment Co., Ltd.; Mirae Asset Venture Investment Co. Ltd.; HB Investment Inc Novelty Nobility Inc
30 Nov 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
01 Oct 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
31 Jan 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit